Ocean Biomedical, Inc.
OCEA
$0.04
-$0.0015-3.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 128.26% | 12.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 128.26% | 12.61% | |||
| Operating Income | -128.26% | -12.61% | |||
| Income Before Tax | 105.12% | 67.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 105.12% | 67.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 105.12% | 67.92% | |||
| EBIT | -128.26% | -12.61% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 105.07% | 67.93% | |||
| Normalized Basic EPS | 105.09% | 67.93% | |||
| EPS Diluted | 105.07% | 67.93% | |||
| Normalized Diluted EPS | 105.09% | 67.93% | |||
| Average Basic Shares Outstanding | 0.66% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.66% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||